Literature DB >> 19755522

Subtype-specific differences in corticotropin-releasing factor receptor complexes detected by fluorescence spectroscopy.

Laura Milan-Lobo1, Ingrid Gsandtner, Erwin Gaubitzer, Dominik Rünzler, Florian Buchmayer, Gottfried Köhler, Antonello Bonci, Michael Freissmuth, Harald H Sitte.   

Abstract

G protein-coupled receptors have been proposed to exist in signalosomes subject to agonist-driven shifts in the assembly disassembly equilibrium, affected by stabilizing membrane lipids and/or cortical actin restricting mobility. We investigated the highly homologous corticotropin-releasing factor receptors (CRFRs), CRFR1 and -2, which are different within their hydrophobic core. Agonist stimulation of CRFR1 and CRFR2 gave rise to similar concentration-response curves for cAMP accumulation, but CRFR2 underwent restricted collision coupling. Both CRFR1 and CRFR2 formed constitutive oligomers at the cell surface and recruited beta-arrestin upon agonist activation (as assessed by fluorescence resonance energy transfer microscopy in living cells). However, CRFR2, but not CRFR1, failed to undergo agonist-induced internalization. Likewise, agonist binding accelerated the diffusion rate of CRFR2 only (detected by fluorescence recovery after photobleaching and fluorescence correlation spectroscopy) but reduced the mobile fraction, which is indicative of local confinement. Fluorescence intensity distribution analysis demonstrated that the size of CRFR complexes was not changed. Disruption of the actin cytoskeleton abolished the agonist-dependent increase in CRFR2 mobility, shifted the agonist concentration curve for CRFR2 to the left, and promoted agonist-induced internalization of CRFR2. Our observations are incompatible with an agonist-induced change in monomer-oligomer equilibrium, but they suggest an agonist-induced redistribution of CRFR2 into a membrane microdomain that affords rapid diffusion but restricted mobility and that is stabilized by the actin cytoskeleton. Our data show that membrane anisotropy can determine the shape and duration of receptor-generated signals in a subtype-specific manner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755522      PMCID: PMC4503342          DOI: 10.1124/mol.109.059139

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

1.  Fluorescence-intensity distribution analysis and its application in biomolecular detection technology.

Authors:  P Kask; K Palo; D Ullmann; K Gall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells.

Authors:  Doreen Wietfeld; Nadja Heinrich; Jens Furkert; Klaus Fechner; Michael Beyermann; Michael Bienert; Hartmut Berger
Journal:  J Biol Chem       Date:  2004-07-12       Impact factor: 5.157

3.  Signaling through a G Protein-coupled receptor and its corresponding G protein follows a stoichiometrically limited model.

Authors:  Finly Philip; Parijat Sengupta; Suzanne Scarlata
Journal:  J Biol Chem       Date:  2007-04-09       Impact factor: 5.157

Review 4.  G proteins control diverse pathways of transmembrane signaling.

Authors:  M Freissmuth; P J Casey; A G Gilman
Journal:  FASEB J       Date:  1989-08       Impact factor: 5.191

5.  Elevated membrane cholesterol concentrations inhibit glucagon-stimulated adenylate cyclase.

Authors:  A D Whetton; L M Gordon; M D Houslay
Journal:  Biochem J       Date:  1983-02-15       Impact factor: 3.857

6.  Monitoring the diffusion of single heterotrimeric G proteins in supported cell-membrane sheets reveals their partitioning into microdomains.

Authors:  Jean-Baptiste Perez; Jean-Manuel Segura; Daniel Abankwa; Joachim Piguet; Karen L Martinez; Horst Vogel
Journal:  J Mol Biol       Date:  2006-08-18       Impact factor: 5.469

7.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein.

Authors:  Matthew R Whorton; Michael P Bokoch; Søren G F Rasmussen; Bo Huang; Richard N Zare; Brian Kobilka; Roger K Sunahara
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

8.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

9.  Glycine transporter dimers: evidence for occurrence in the plasma membrane.

Authors:  Ingo Bartholomäus; Laura Milan-Lobo; Annette Nicke; Sébastien Dutertre; Hanne Hastrup; Alok Jha; Ulrik Gether; Harald H Sitte; Heinrich Betz; Volker Eulenburg
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

Review 10.  International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers.

Authors:  Jean-Philippe Pin; Richard Neubig; Michel Bouvier; Lakshmi Devi; Marta Filizola; Jonathan A Javitch; Martin J Lohse; Graeme Milligan; Krzysztof Palczewski; Marc Parmentier; Michael Spedding
Journal:  Pharmacol Rev       Date:  2007-03       Impact factor: 25.468

View more
  15 in total

1.  The Pseudo signal peptide of the corticotropin-releasing factor receptor type 2A prevents receptor oligomerization.

Authors:  Anke Teichmann; Claudia Rutz; Annika Kreuchwig; Gerd Krause; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

2.  The pseudo signal peptide of the corticotropin-releasing factor receptor type 2a decreases receptor expression and prevents Gi-mediated inhibition of adenylyl cyclase activity.

Authors:  Katharina Schulz; Claudia Rutz; Carolin Westendorf; Ingrid Ridelis; Susanne Vogelbein; Jens Furkert; Antje Schmidt; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

3.  Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.

Authors:  Richard L Hauger; J Alberto Olivares-Reyes; Sandra Braun; Judith Hernandez-Aranda; Christine C Hudson; Eric Gutknecht; Frank M Dautzenberg; Robert H Oakley
Journal:  Regul Pept       Date:  2013-06-29

4.  Regulation of GABA(A) receptor dynamics by interaction with purinergic P2X(2) receptors.

Authors:  Amulya Nidhi Shrivastava; Antoine Triller; Werner Sieghart; Isabella Sarto-Jackson
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

Review 5.  Don't stress about CRF: assessing the translational failures of CRF1antagonists.

Authors:  Samantha R Spierling; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

6.  The cell adhesion molecule neuroplastin-65 is a novel interaction partner of γ-aminobutyric acid type A receptors.

Authors:  Isabella Sarto-Jackson; Ivan Milenkovic; Karl-Heinz Smalla; Eckart D Gundelfinger; Thilo Kaehne; Rodrigo Herrera-Molina; Sabine Thomas; Michael A Kiebler; Werner Sieghart
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

7.  The specific monomer/dimer equilibrium of the corticotropin-releasing factor receptor type 1 is established in the endoplasmic reticulum.

Authors:  Anke Teichmann; Arthur Gibert; André Lampe; Paul Grzesik; Claudia Rutz; Jens Furkert; Jan Schmoranzer; Gerd Krause; Burkhard Wiesner; Ralf Schülein
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

8.  Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine.

Authors:  Gemma Navarro; César Quiroz; David Moreno-Delgado; Adam Sierakowiak; Kimberly McDowell; Estefanía Moreno; William Rea; Ning-Sheng Cai; David Aguinaga; Lesley A Howell; Felix Hausch; Antonio Cortés; Josefa Mallol; Vicent Casadó; Carme Lluís; Enric I Canela; Sergi Ferré; Peter J McCormick
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

Review 9.  Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.

Authors:  Marisa Roberto; Samantha R Spierling; Dean Kirson; Eric P Zorrilla
Journal:  Int Rev Neurobiol       Date:  2017-08-07       Impact factor: 3.230

10.  Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety.

Authors:  K S Sink; D L Walker; S M Freeman; E I Flandreau; K J Ressler; M Davis
Journal:  Mol Psychiatry       Date:  2012-01-31       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.